Independent Data Monitoring Committees play a critical role for any clinical trial. They are usually the only body that sees accumulating, comparative data from the trial. There have been few ...

A user-friendly ePRO monitoring system can reduce patient uncertainty regarding disease management and promote patient-centered cardiovascular care.” 1 1. Yamashita S, Katsumata Y, Kohsaka S, et al.

Today, Editas is the only one of the original three CRISPR companies without any medicines in clinical trials. Its first program, in a rare eye disease, failed in 2022 after extensive delays.

Zejula (niraparib) is a PARP inhibitor approved to treat several gynaecological cancers. TIVDAK is approved in the US based on results from the same Phase III innovaTV 301 clinical trial. Results from ...

The PST-611-CT1 Phase I trial ... clinical studies with our lead program PST-611. PST-611 has shown unique features in terms of efficacy, safety and durability of effect in a robust preclinical plan.

Patient enrollment has been completed ahead of schedule in a Phase 2 clinical trial evaluating Contineum Therapeutics‘ PIPE-307, an oral therapy aiming to restore myelin — a process known as ...

The ALIVE clinical ... This allowed the trial to proceed to Phase III, where efficacy was assessed in a much larger number of participants, alongside continued safety monitoring.

Get Instant Summarized Text (Gist) A new drug, NXP800, shows promise in treating hormone therapy-resistant prostate cancer by targeting the Heat Shock Factor 1 (HSF1) pathway, which supports ...